Del-1 Plays a Protective Role against COPD Development by Inhibiting Inflammation and Apoptosis

Nakwon Kwak,Kyoung-Hee Lee,Jisu Woo,Jiyeon Kim,Jimyung Park,Chang-Hoon Lee,Chul-Gyu Yoo

DOI: https://doi.org/10.3390/ijms25041955

IF: 5.6

2024-02-07

International Journal of Molecular Sciences

Abstract:Neutrophilic inflammation is a prominent feature of chronic obstructive pulmonary disease (COPD). Developmental endothelial locus-1 (Del-1) has been reported to limit excessive neutrophilic inflammation by inhibiting neutrophil adhesion to the vascular endothelial cells. However, the effects of Del-1 in COPD are not known. We investigated the role of Del-1 in the pathogenesis of COPD. Del-1 protein expression was decreased in the lungs of COPD patients, especially in epithelial cells and alveolar macrophages. In contrast to human lung tissue, Del-1 expression was upregulated in lung tissue from mice treated with cigarette smoke extracts (CSE). Overexpression of Del-1 significantly suppressed IL-8 release and apoptosis in CSE-treated epithelial cells. In contrast, knockdown of Del-1 enhanced IL-8 release and apoptosis. In macrophages, overexpression of Del-1 significantly suppressed inflammatory cytokine release, and knockdown of Del-1 enhanced it. This anti-inflammatory effect was mediated by inhibiting the phosphorylation and acetylation of NF-κB p65. Nuclear factor erythroid 2-related factor 2 (Nrf2) activators, such as quercetin, resveratrol, and sulforaphane, increased Del-1 in both cell types. These results suggest that Del-1, mediated by Nrf2, plays a protective role against the pathogenesis of COPD, at least in part through anti-inflammatory and anti-apoptotic effects.

biochemistry & molecular biology,chemistry, multidisciplinary

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the role of Developmental endothelial locus - 1 (Del - 1) in chronic obstructive pulmonary disease (COPD) and its underlying mechanisms. Specifically, the study aims to verify whether Del - 1 exerts a protective effect by inhibiting inflammation and apoptosis, thereby counteracting the development of COPD. ### Overview of Main Problems 1. **Changes in Del - 1 Expression in COPD**: - Researchers first measured the expression levels of Del - 1 in the lung tissues of non - COPD patients and COPD patients and found that the expression of Del - 1 protein in the lung tissues of COPD patients was significantly reduced, especially in epithelial cells and macrophages. 2. **The Influence of Del - 1 on Inflammation**: - Through experiments, researchers found that over - expression of Del - 1 could significantly inhibit IL - 8 release and inflammatory reactions induced by cigarette smoke extract (CSE), while knockdown of Del - 1 enhanced these inflammatory reactions. In addition, in macrophages, over - expression of Del - 1 also significantly inhibited the release of inflammatory cytokines, while knockdown of Del - 1 enhanced the release of these cytokines. 3. **The Influence of Del - 1 on Apoptosis**: - Over - expression of Del - 1 significantly inhibited CSE - induced apoptosis, manifested as a reduction in activated caspase - 3 and PARP cleavage; while knockdown of Del - 1 exacerbated this apoptotic response. 4. **The Influence of Del - 1 on the NF - κB Pathway**: - Studies have shown that Del - 1 exerts an anti - inflammatory effect by inhibiting the phosphorylation and acetylation of the NF - κB p65 subunit, reducing its DNA - binding ability and transcriptional activity. This process does not involve the inactivation of the MAP kinase pathway. 5. **The Influence of Nrf2 Activators on Del - 1 Expression**: - The study also found that Nrf2 activators such as quercetin, resveratrol, and sulforaphane can increase the expression of Del - 1, suggesting that Nrf2 may play an important role in regulating Del - 1 expression. ### Conclusion This study shows that Del - 1 has a protective role in the development of COPD, mainly achieved by inhibiting inflammation and apoptosis. In addition, Nrf2 activators may become a potential treatment strategy to increase the expression of Del - 1 and thus counteract the development of COPD.

Del-1 Plays a Protective Role against COPD Development by Inhibiting Inflammation and Apoptosis

Egr-1 Regulates Autophagy in Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease.

Zl-n-91, a Selective Phosphodiesterase 4 Inhibitor, Suppresses Inflammatory Response in a COPD-like Rat Model.

Del-1, an Endogenous Inhibitor of TGF-β Activation, Attenuates Fibrosis

DEL-1, as an anti-neutrophil transepithelial migration molecule, inhibits airway neutrophilic inflammation in asthma

Knockdown of RTEL1 Alleviates Chronic Obstructive Pulmonary Disease by Modulating M1, M2 Macrophage Polarization and Inflammation

LINC00612/miR-31-5p/Notch1 Axis Regulates Apoptosis, Inflammation, and Oxidative Stress in Human Pulmonary Microvascular Endothelial Cells Induced by Cigarette Smoke Extract

Nrf2/HO-1 signaling activation alleviates cigarette smoke-induced inflammation in chronic obstructive pulmonary disease by suppressing NLRP3-mediated pyroptosis

Activation of Hypoxia-Inducible Factor-1 Alpha Via Nuclear Factor-Kappa B in Rats with Chronic Obstructive Pulmonary Disease

RIPK1 kinase-dependent inflammation and cell death contribute to the pathogenesis of COPD

Cigarette smoke-induced lung inflammation in COPD mediated via CCR1/JAK/STAT /NF-κB pathway

DJ-1 modulates Nrf2-mediated MRP1 expression by activating Wnt3a/β-catenin signalling in A549 cells exposed to cigarette smoke extract and LPS

PU.1 alleviates the inhibitory effects of cigarette smoke on endothelial progenitor cell function and lung-homing through Wnt/β-catenin and CXCL12/CXCR4 pathways

Reduced Tolerogenic Program Death-Ligand 1-Expressing Conventional Type 1 Dendritic Cells Are Associated with Rapid Decline in Chronic Obstructive Pulmonary Disease

Interaction between CD244 and SHP2 regulates inflammation in chronic obstructive pulmonary disease via targeting the MAPK/NF-κB signaling pathway

Inactivation of the TGF-β1/ALK5 axis enhances club cell function and alleviates lung tissue damage to ameliorate COPD progression through the MEK/ERK signaling pathway

Developmental endothelial locus-1 protects from hypertension-induced cardiovascular remodeling via immunomodulation

Expression of long non‐coding RNA LUCAT1 in patients with chronic obstructive pulmonary disease and its potential functions in regulating cigarette smoke extract‐induced 16HBE cell proliferation and apoptosis

Long non-coding RNA NNT-AS1 regulates proliferation, apoptosis, inflammation and airway remodeling of chronic obstructive pulmonary disease via targeting miR-582-5p/FBXO11 axis

NOD1 agonist iE-DAP reverses effects of cigarette smoke extract on NOD1 signal pathway in human oral mucosal epithelial cells.

XIST promotes apoptosis and the inflammatory response in CSE-stimulated cells via the miR-200c-3p/EGR3 axis